The results of this study align with previous findings, indicating that the sensitivity and specificity of CEA and CA15-3 in BC diagnosis were suboptimal.[13] Therefore, monitoring CEA and CA15-3 alone may not meet clinical needs. The gene discussed is CEACAM5; the disease is breast cancer.